Rotavirus vaccine (2025)

Concepts

• vaccines
• rotavirus vaccine
• a specific vaccine
• vaccine
• rotavirus
• the national immunisation programme
• the legitimate commercial interest
• the public contracts regulations
• the supplier
• years

Location

United Kingdom: Lutterworth, UK

Geochart for 1 buyers and 1 suppliers

Secretary of State for Health & Social Care Acting as Part of the Crown Through UK Health Security Agency

Glaxosmithkline

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

Provision for the supply of rotavirus vaccine (2025)

Total Quantity or Scope

The provision of rotavirus vaccine to be used as part of the national immunisation programme.Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.The opportunity is not split into lots as the requirement is for a specific vaccine. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Award Detail

Renewal Options

This contract has the option to be extended for a period or periods up to an additional 24 months

Award Criteria

CPV Codes

• 33651600 - Vaccines

Indicators

• Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.